[1]
Boujediane, O., Erdozain, A.M. and Ortega, J.E. 2021. Benefit/risk assessment of SARS-CoV-2 vaccines approved in the European Union. Osagaiz: osasun-zientzien aldizkaria. 5, 2 (Dec. 2021). DOI:https://doi.org/10.26876/osagaiz.2.2021.409.